ADIM
MODV

Alpha DNA Investment Management’s ModivCare MODV Stock Holding History

Alpha DNA Investment Management’s Portfolio MODV Stock Details MODV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-31
Closed -$4K – 428
2021
Q1 		$4K Buy
+31
New +$4.82K ﹤0.01% 415

Other funds holding MODV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alpha DNA Investment Management's MODV Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of ModivCare (MODV) in Q2 2021, closing a stake of 31 shares — an estimated $4K sold.

Alpha DNA Investment Management first reported a position in MODV in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 193 funds tracked by Wall St. Rank hold MODV as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining ModivCare position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 31 ModivCare shares in Q2 2021, an estimated $4K.
  • Alpha DNA Investment Management first reported a position in ModivCare in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's ModivCare position peaked at $4K in Q1 2021.
  • 193 funds tracked by Wall St. Rank held ModivCare as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.